SSelectStock
Sign in

MEDANTAGlobal Health Limited

Healthcare · Medical Care Facilities · NSE · as of 2026-07-20 (delayed ~30 min in market hours)

1,331.40
1.10%
71Strong

Price & Volume

Loading chart…

Key Ratios

Market Cap (₹ cr)35,495.10
P/E63.75
P/B8.96
PEG1.52
ROE %15.03
ROCE %13.50
Debt / Equity0.30
EPS20.72
Revenue Growth %24.50
Profit Growth %42.00
Dividend Yield %0.04
Promoter Holding %67.12
FII Holding %23.09
DII Holding %
Beta0.16

“—” means the figure isn't meaningful or isn't published for this company: ROE and Debt/Equity are undefined when shareholder equity is negative (check P/B — negative means negative equity), and DII/MF holding splits aren't provided by our current data source.

Active Pattern Signals

Pullback to 21-EMALONG76%1,331.401,305.001,396.102.45
Cup & HandleLONG70%1,331.401,295.901,508.905.00
BUYConviction 86%

Why buy

  • Revenue growth: 24.5% YoY
  • Profit growth: 42.0% YoY
  • Debt/Equity: 0.30
  • RSI: 57
  • Price vs EMA21: above
  • Price vs SMA50: above
  • Cup & Handle signal (setup quality 70%)
  • Pullback to 21-EMA signal (setup quality 76%)

Bull case

  • Revenue growth: 24.5% YoY
  • Profit growth: 42.0% YoY
  • Debt/Equity: 0.30
  • RSI: 57

Bear case

  • Dividend yield: 0.04%
  • MACD: bearish
  • Volume: 0.4x 20-day average
  • Volume trend: 0.4x baseline

Key risks

  • Dividend yield: 0.04%
  • MACD: bearish

Algorithmic analysis for research only — not SEBI-registered investment advice.

Trade Plan

Entry (CMP)
₹1,331.40
Stop Loss
₹1,272.15
risk 4.5%
Target 1 (1.5R)
₹1,420.28
+6.7%
Target 2 (3R)
₹1,509.15
+13.4%
Support (20d)
₹1,285.00
Resistance (52w)
₹1,455.98
Risk : Reward
1 : 1.5 → 1 : 3
risking ₹59.25/share
ATR (volatility)
₹30.77
avg daily range

Stop = 20-day support with a 2.5×ATR risk cap (ATR ₹30.77). Levels recompute on every data refresh. Position sizing and execution are yours — this is analysis, not advice.

Score Breakdown

Fundamental
77
Technical
67
Momentum
75
Risk (safety)
62

Peers — Healthcare

IKS 0.25%
83
THYROCARE 6.70%
80
METROPOLIS 5.22%
76
RAINBOW 0.07%
74
APOLLOHOSP 0.90%
74
PARKHOSPS 1.84%
71

About

Global Health Limited, together with its subsidiaries, provides healthcare services in India. The company offers treatments in the areas of digestive and hepatobiliary sciences, cardiac and cancer care, neurosciences, gastrosciences, orthopaedics, renal care, liver transplant, lung transplant, bone marrow transplant, chest surgery, gynaecology and gynaeoncology, paediatric care, obstetrics, emergency, ENT, head and neck surgery, internal medicine, respiratory and sleep medicine, peripheral vascular and endovascular sciences, endocrinology and diabetes, rheumatology and immunology, radiology and imaging, ophthalmology, critical care, dermatology, dentistry, and dietetics and nutrition, as well as plastic, aesthetic, and reconstructive surgery. It also provides second opinion, lab tests and diagnostics, homecare and elder care services, telemedicine and air ambulance services, and e-ICU services, and health plans checkup. In addition, the company is involved in trading of pharmacy and other medical consumables; and medical and healthcare education activities. The company operates a network of hospitals under the Medanta brand. Global Health Limited was incorporated in 2004 and is based in Gurugram, India.